Berberine and total base from rhizoma coptis chinensis attenuate brain injury in an aluminum-induced rat model of neurodegenerative disease

Saudi Medical Journal

Volumn 30, Issue 6, 2009, Pages 760-766

  Zhang, Jing ^a   Yang, Jun Qing ^a   He, Bai Cheng ^a   Zhou, Qi Xin ^a   Yu, Hua Rong ^a   Tang, Yong ^a   Liu, Bei Zhong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ALUMINUM; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BERBERINE; CHOLINE ACETYLTRANSFERASE; COPTIS CHINENSIS EXTRACT; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE MODEL; DOSE RESPONSE; DRUG DOSE COMPARISON; ENZYME ACTIVITY; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; LEARNING; LOCOMOTION; MALE; MEMORY; NERVE CELL; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE; PROTEIN EXPRESSION; RAT; STEP DOWN LATENCY; WISTAR RAT;

ALUMINUM; ANIMALS; BERBERINE; BRAIN INJURIES; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; MALE; NEURODEGENERATIVE DISEASES; RATS; RATS, WISTAR;

EID: 67651176124     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Golde TE. Inflammation takes on Alzheimer disease. Nat Med 2002; 8: 936-938.
2. Wang XL, Xing DM, Wang W, Su H, Tao JL, Du LJ. Pharmacokenetics of berberine in rat thalamus after intravenous administration of coptidis rhizoma extract. American Journal of Chinese Medicine 2005; 33; 935-943.
3. Wang X, Wang R, Xing D, Su H, Ma C, Ding Y, et al. Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract. Life Sci 2005; 77: 3058-3067.
4. Kulkarni SK, Dhir A. On the mechanism of antidepressant-like action of berberine chloride. Eur J Pharmacol 2008; 589: 163-172.
5. Lee B, Yang CH, Hahm DH, Lee HJ, Choe ES, Pyun KH, et al. Coptidis Rhizoma attenuates repeated nicotine-induced behavioural sensitization in the rat. J Pharm Pharmacol 2007; 59: 1663-1669.
6. Zhou XQ, Zeng XN, Kong H, Sun XL. Neuroprotective effects of berberine on stroke models in vitro and in vivo. Neurosci Lett 2008; 447: 31-36.
7. Yoo KY, Hwang IK, Kim JD, Kang IJ, Park J, Yi JS, et al. Antiinflammatory effect of the ethanol extract of Berberis koreana in a gerbil model of cerebral ischemia/reperfusion. Phytother Res 2008; 22: 1527-1532.
8. Yang ZQ, Yang SF, Yang JQ, Zhou QX, Li SL. Protective effects and mechanism of total coptis alkaloids on a beta 25-35 induced learning and memory dysfunction in rats. Chin J Integr Med 2007; 13: 50-54.
9. Cui HS, Matsumoto K, Murakami Y, Hori H, Zhao Q, Obi R. Berberine exerts neuroprotective actions against in vitro ischemia-induced neuronal cell damage in organotypic hippocampal slice cultures: Involvement of B-cell lymphoma 2 phosphorylation suppression. Biol Pharm Bull 2009; 32: 79-85.
10. Yang JQ, Zhou QX, Liu BZ, He BC. Protection of mouse brain from aluminum-induced damage by caffeic acid. CNS Neurosci Ther 2008; 14: 10-16.
11. De Marchi U, Mancon M, Battaglia V, Ceccon S, Cardellini P, Toninello A. Influence of reactive oxygen species production by monoamine oxidase activity on aluminum-induced mitochondrial permeability transition. Cell Mol Life Sci 2004; 61: 2664-2671.
12. Youdim MB. The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30. Curr Alzheimer Res 2006; 3: 541-550.
13. Huh JW, Choi MM, Lee JH, Yang SJ, Kim MJ, Choi J, et al. Activation of monoamine oxidase isotypes by prolonged intake of aluminum in rat brain. J Inorg Biochem 2005; 99: 2088-2091.